Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Sanatorio Diagnóstico

Santa Fe, 3081, ArgentinaNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Coronary artery disease
Heart failure

Closed trials

Completed
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
NCT04509674· Phase 3· Boehringer Ingelheim· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Sanatorio Diagnóstico: trial site – Frontlight Research